Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of two rivaroxaban 20 mg tablet formulations under fed conditions in healthy Thai volunteers
TCTR20220721003Phase 1Not yet recruiting
- Sponsor
- Sun Pharma
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of rivaroxaban (2 arms), sponsored by Sun Pharma. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
rivaroxaban
Beyond the preview
Go deeper on TCTR20220721003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220721003.